The North America Genomics market is expected to reach US$ 20,348.43 million in 2027 from US$ 7,669.34 million in 2019. The market is estimated to grow with a CAGR of 13.3% from 2020-2027.
Genomics is defined as the study of a gene and its functioning. Genomics is used to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications. The scope of the genomics market includes technology, product and service, application, end-user, and region.
US Genomics Market Revenue and Forecasts to 2027 (US$ MN)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA GENOMICS MARKET SEGMENTATION
By Technology
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
By Product and Services
- Instruments/Systems
- Consumables
- Services
By Application
- Diagnostics
- Drug Discovery and Development
- Precision/Personalized Medicine
- Agriculture & Animal Research
- Others
By End User
- Research Centers
- Hospitals & Clinics
- Biotechnology & Pharmaceutical Companies
- Others
By Country
North America
- US
- Canada
- Mexico
Company Profiles
- Illumina, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- BIO-RAD LABORATORIES INC.
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- Agilent Technologies, Inc.
- Eurofins Scientific
- QIAGEN
- BGI
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Product & Service, Application, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Genomics Market – By Technology
1.3.2 Genomics Market – By Product& Services
1.3.3 Genomics Market – ByApplication
1.3.4 Genomics Market – By End User
1.3.5 North AmericaGenomics Market– By Country
2. North America Genomics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Genomics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Genomics Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Genomics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Public-Private Funding in Genomics Market
5.1.2 High Growth in the Pharmaceutical and Biotechnology Sectors
5.2 Market Restraints
5.2.1 Lack of Funds in Developing Nations and a Dearth of Skilled Professionals in the Healthcare Sector
5.3 Market Opportunities
5.3.1 Rising Adoption of Precision Medicines
5.4 Future Trends
5.4.1 High Rise in Innovations and Technological Advancements Regarding Genomics
5.5 Impact Analysis
6. Genomics Market – North America Analysis
6.1 North America Genomics Market Revenue Forecasts and Analysis
7. North America Genomics Market Analysis and Forecasts To 2027 – ByTechnology
7.1 Overview
7.2 Genomics Market Revenue Share, by Technology (2019 and 2027)
7.3 Sequencing
7.3.1 Overview
7.3.2 Sequencing: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Microarray
7.4.1 Overview
7.4.2 Microarray: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Polymerase Chain Reaction (PCR)
7.5.1 Overview
7.5.2 Polymerase Chain Reaction (PCR): Genomics Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Nucleic Acid Extraction and Purification
7.6.1 Overview
7.6.2 Nucleic Acid Extraction and Purification: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
8. North America Genomics Market Analysis and Forecasts To 2027 – ByProduct and Service
8.1 Overview
8.2 Genomics Market Revenue Share, by Product & Service (2019 and 2027)
8.3 Instruments/Systems
8.3.1 Overview
8.3.2 Instruments/Systems: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Genomics Market Analysis – ByApplication
9.1 Overview
9.2 Genomics Market, by Application, 2019 and 2027 (%)
9.3 Diagnostics
9.3.1 Overview
9.3.2 Diagnostics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Drug Discovery and Development
9.4.1 Overview
9.4.2 Drug Discovery and Development: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Precision/Personalized Medicine
9.5.1 Overview
9.5.2 Precision/Personalized Medicine: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Agricultural & Animal Research
9.6.1 Overview
9.6.2 Agricultural & Animal Research: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Genomics Market Analysis – By End-User
10.1 Overview
10.2 Genomics Market, by End-User, 2019 and 2027 (%)
10.4 ResearchCentres
10.4.1 Overview
10.4.2 ResearchCentres: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Hospitals& Clinics
10.5.1 Overview
10.5.2 Hospitals & Clinics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Pharmaceutical & Biotechnology Companies
10.6.1 Overview
10.6.2 Pharmaceutical & Biotechnology Companies: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
11. Genomics Market Revenue and Forecasts To 2027 – Geographical Analysis
11.1 North America: Genomics Market
11.1.1 Overview
11.1.2 North America: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Genomics Market, by Technology, 2018–2027 (USD Million)
11.1.4 North America: Genomics Market, by Product and Service, 2018–2027 (USD Million)
11.1.5 North America: Genomics Market, by Application, 2018–2027 (Million Units)
11.1.6 North America: Genomics, Market, by End User, 2018–2027 (USD Million)
11.1.7 North America: Genomics Market, by Country, 2019 & 2027 (%)
11.1.8 US: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Genomics Market, by Technology, 2018–2027 (USD Million)
11.1.8.3 US: Genomics Market, by Product and Service, 2018–2027 (USD Million)
11.1.8.4 US: Genomics Market, by Application, 2018–2027 (Million Units)
11.1.8.5 US: Genomics, Market, by End User, 2018–2027 (USD Million)
11.1.9 Canada: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Genomics Market, by Technology, 2018–2027 (USD Million)
11.1.9.3 Canada: Genomics Market, by Product and Service, 2018–2027 (USD Million)
11.1.9.4 Canada: Genomics Market, by Application, 2018–2027 (Million Units)
11.1.9.5 Canada: Genomics, Market, by End User, 2018–2027 (USD Million)
11.1.10 Mexico: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Genomics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Genomics Market, by Technology, 2018–2027 (USD Million)
11.1.10.3 Mexico: Genomics Market, by Product and Service, 2018–2027 (USD Million)
11.1.10.4 Mexico: Genomics Market, by Application, 2018–2027 (Million Units)
11.1.10.5 Mexico: Genomics, Market, by End User, 2018–2027 (USD Million)
12. Impact of COVID-19 Pandemic on North America Genomics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. COMPANY PROFILES
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BIO-RAD LABORATORIES INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 General Electric Company
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 THERMO FISHER SCIENTIFIC INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BGI
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of terms
LIST OF TABLES
Table 1. North America: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Genomics Market, by Product and Service– Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)
Table 4. North America: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. US: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 6. US: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)
Table 8. US: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: Genomics Market, by Product and Service– Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)
Table 12. Canada: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)
Table 16. Mexico: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Glossary of Terms,Genomics Market
LIST OF FIGURES
Figure 1. GenomicsMarket Segmentation
Figure 2. North America Genomics Market Overview
Figure 3. SequencingSegment Held Largest Share of Technology inGenomicsMarket
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Genomics Market - North America PEST Analysis
Figure 6. Genomics Market Impact Analysis of Driver and Restraints
Figure 7. North America Genomics Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Genomics Market Revenue Share, by Technology (2019 and 2027)
Figure 9. Sequencing: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Microarray: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Polymerase Chain Reaction (PCR): Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Nucleic Acid Extraction and Purification: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Genomics Market Revenue Share, by Product & Service (2019 and 2027)
Figure 15. Instruments/Systems: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Consumables: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Services: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Genomics Market, by Application, 2019 and 2027 (%)
Figure 19. Diagnostics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Drug Discovery and Development: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Precision/Personalized Medicine: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Agricultural & Animal Research: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Genomics Market, by End-User, 2019 and 2027 (%)
Figure 25. Research Centers: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Hospitals & Clinics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Pharmaceutical & Biotechnology Companies: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other End-Users: Genomics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. North America: Genomics Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. North America: Genomics Market Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Genomics Market, by Country, 2019 & 2027 (%)
Figure 32. US: Genomics Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Canada: Genomics Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Mexico: Genomics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in North America Country Markets
- Illumina, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- BIO-RAD LABORATORIES INC.
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- Agilent Technologies, Inc.
- Eurofins Scientific
- QIAGEN
- BGI
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Genomics Market
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2021